BioAge Labs (BIOA) Depreciation and Depletion (2023 - 2026)
BioAge Labs' (BIOA) quarterly Depreciation and Depletion came in at $63000.0 in Q1 2026, up 70.27% year-on-year from $37000.0 in Q1 2025, and up 12.5% quarter-over-quarter from $56000.0 in Q4 2025.
BioAge Labs (BIOA) Depreciation and Depletion (2023 - 2026) Analysis & Trends
BioAge Labs has disclosed Depreciation and Depletion across 4 years of filings, most recently posting $63000.0 for Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $63000.0, up 70.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $319000.0 (up 0.63% YoY), and the FY2025 annual result was $200000.0, changed 0.0% from the prior year.
- Depreciation and Depletion came in at $63000.0 for Q1 2026 at BioAge Labs, up from $56000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $100000.0 in Q3 2023 to a low of $33000.0 in Q1 2024.
- The 4-year median for Depreciation and Depletion is $80000.0 (2024), against an average of $77090.9.
- Across the five-year window, Depreciation and Depletion slumped 30.0% in 2025 and surged 70.27% in 2026, its largest moves.
- BioAge Labs' Depreciation and Depletion stood at $79000.0 in 2023, then rose by 1.27% to $80000.0 in 2024, then dropped by 30.0% to $56000.0 in 2025, then climbed by 12.5% to $63000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $63000.0 (Q1 2026), $56000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | BioAge Labs | 671.19 Mn | 288.00 Mn | -10.37 Mn | 63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,000.00 |
| Mar 31, 2026 | 63,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 33,000.00 |
| Mar 31, 2024 | 33,000.00 |
| Dec 31, 2023 | 79,000.00 |
| Dec 31, 2023 | 79,000.00 |